OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nitazoxanide and COVID-19: A review
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 11169-11176
Open Access | Times Cited: 40
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 11169-11176
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 37-56
Open Access | Times Cited: 62
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 37-56
Open Access | Times Cited: 62
Traditional herbs against COVID-19: back to old weapons to combat the new pandemic
Hayder M. Al‐kuraishy, Omnia Momtaz Al-Fakhrany, Engy Elekhnawy, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 49
Hayder M. Al‐kuraishy, Omnia Momtaz Al-Fakhrany, Engy Elekhnawy, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 49
DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 923-936
Closed Access | Times Cited: 20
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 923-936
Closed Access | Times Cited: 20
Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma
Amal B. Ahmed, Maha M. Abdelrahman, Fadwa H. Edrees
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
Amal B. Ahmed, Maha M. Abdelrahman, Fadwa H. Edrees
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2271-2279
Open Access | Times Cited: 14
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2271-2279
Open Access | Times Cited: 14
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics
Zirui Lü, Xiandong Dai, Jianjie Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116442-116442
Closed Access | Times Cited: 3
Zirui Lü, Xiandong Dai, Jianjie Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116442-116442
Closed Access | Times Cited: 3
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
Irisin/PGC-1α/FNDC5 pathway in Parkinson’s disease: truth under the throes
Naif H. Ali, Nourah Alhamdan, Hayder M. Al‐kuraishy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 1985-1995
Closed Access | Times Cited: 10
Naif H. Ali, Nourah Alhamdan, Hayder M. Al‐kuraishy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 1985-1995
Closed Access | Times Cited: 10
Nitazoxanide reduces inflammation and bone erosion in mice with collagen-induced arthritis via inhibiting the JAK2/STAT3 and NF-κB pathways in fibroblast-like synoviocytes
Changhong Li, Fengliang Wang, Yijun Han, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116195-116195
Open Access | Times Cited: 3
Changhong Li, Fengliang Wang, Yijun Han, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116195-116195
Open Access | Times Cited: 3
The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one
Mina Kelleni
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3335-3338
Open Access | Times Cited: 9
Mina Kelleni
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3335-3338
Open Access | Times Cited: 9
Role of fenofibrate in multiple sclerosis
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Oxfendazole Nitazoxanide combination in experimental neurocysticercosis – Anti-inflammatory and cysticidal effects
J. A. Araujo, Taynara Cristina Gomes, Vanessa Cindy Neres Lima, et al.
Experimental Parasitology (2024) Vol. 262, pp. 108764-108764
Closed Access | Times Cited: 2
J. A. Araujo, Taynara Cristina Gomes, Vanessa Cindy Neres Lima, et al.
Experimental Parasitology (2024) Vol. 262, pp. 108764-108764
Closed Access | Times Cited: 2
An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment Strategies
Pooja Kumawat, Lokesh Kumar Agarwal, Kuldeep Sharma
Current Microbiology (2024) Vol. 81, Iss. 7
Closed Access | Times Cited: 2
Pooja Kumawat, Lokesh Kumar Agarwal, Kuldeep Sharma
Current Microbiology (2024) Vol. 81, Iss. 7
Closed Access | Times Cited: 2
Amebicides against Acanthamoeba castellanii: The Impact of Organism Models Used in Amebicide Assays
Leonardo Fernandes Geres, Elena Sartori, João Marcos dos Santos Neves, et al.
Parasitologia (2024) Vol. 4, Iss. 1, pp. 15-37
Open Access | Times Cited: 1
Leonardo Fernandes Geres, Elena Sartori, João Marcos dos Santos Neves, et al.
Parasitologia (2024) Vol. 4, Iss. 1, pp. 15-37
Open Access | Times Cited: 1
Transcriptional Differential Analysis of Nitazoxanide-Mediated Anticanine Parvovirus Effect in F81 Cells
Xia Su, Hongzhuan Zhou, Ziwei Han, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 282-282
Open Access | Times Cited: 1
Xia Su, Hongzhuan Zhou, Ziwei Han, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 282-282
Open Access | Times Cited: 1
Synthesis and characterization of polyethyleneimine grafted lignocellulosic fibers for improved removal of nitazoxanide and ampicillin from water
Juliê S. da Costa, Débora R.S. dos Santos, Marcela B. Alvarez, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 693, pp. 134063-134063
Closed Access | Times Cited: 1
Juliê S. da Costa, Débora R.S. dos Santos, Marcela B. Alvarez, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 693, pp. 134063-134063
Closed Access | Times Cited: 1
Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1
A Drug-Virus Prediction Model Based on an Ensemble Classifier with Feature Optimization: A Case Study with COVID-19
Ajithadas Aruna, K. R. Remesh Babu, K. Deepthi
Lecture notes in networks and systems (2024), pp. 267-280
Closed Access | Times Cited: 1
Ajithadas Aruna, K. R. Remesh Babu, K. Deepthi
Lecture notes in networks and systems (2024), pp. 267-280
Closed Access | Times Cited: 1
From Defense to Dysfunction: Autophagy's Dual Role in Disease Pathophysiology
Jonaid Ahmad Malik, Mohammad Adeel Zafar, Sanpreet Singh, et al.
European Journal of Pharmacology (2024) Vol. 981, pp. 176856-176856
Closed Access | Times Cited: 1
Jonaid Ahmad Malik, Mohammad Adeel Zafar, Sanpreet Singh, et al.
European Journal of Pharmacology (2024) Vol. 981, pp. 176856-176856
Closed Access | Times Cited: 1
Antibacterial and wound healing potential of biosynthesized zinc oxide nanoparticles against carbapenem-resistant Acinetobacter baumannii: an in vitro and in vivo study
M. Selim, Fatma Sonbol, Tarek El-Said El-Banna, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
M. Selim, Fatma Sonbol, Tarek El-Said El-Banna, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Mohamed Abuelazm, Ahmed Ghanem, Ahmed K. Awad, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 12, pp. 1031-1047
Open Access | Times Cited: 9
Mohamed Abuelazm, Ahmed Ghanem, Ahmed K. Awad, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 12, pp. 1031-1047
Open Access | Times Cited: 9
Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis
Ashwini Shete, Supriya Deshpande, Jyoti Sawant, et al.
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152384-152384
Open Access | Times Cited: 4
Ashwini Shete, Supriya Deshpande, Jyoti Sawant, et al.
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152384-152384
Open Access | Times Cited: 4
The Potential Effect of Dapsone on the Inflammatory Reactions in COVID-19: Staggering View
Hayder Alkuraishy, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 27, Iss. 5, pp. 674-678
Closed Access | Times Cited: 3
Hayder Alkuraishy, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 27, Iss. 5, pp. 674-678
Closed Access | Times Cited: 3
